ES2175425T3 - Antibiotico micrococcina para la prevencion y tratamiento de la mastitis. - Google Patents

Antibiotico micrococcina para la prevencion y tratamiento de la mastitis.

Info

Publication number
ES2175425T3
ES2175425T3 ES97929226T ES97929226T ES2175425T3 ES 2175425 T3 ES2175425 T3 ES 2175425T3 ES 97929226 T ES97929226 T ES 97929226T ES 97929226 T ES97929226 T ES 97929226T ES 2175425 T3 ES2175425 T3 ES 2175425T3
Authority
ES
Spain
Prior art keywords
micrococcina
mastitis
treatment
antibiotico
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97929226T
Other languages
English (en)
Spanish (es)
Inventor
Bruno Suri
Catherine Georges
John Edmondson Peel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2175425T3 publication Critical patent/ES2175425T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/05—Treating milk before coagulation; Separating whey from curd
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
ES97929226T 1996-06-20 1997-06-19 Antibiotico micrococcina para la prevencion y tratamiento de la mastitis. Expired - Lifetime ES2175425T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20

Publications (1)

Publication Number Publication Date
ES2175425T3 true ES2175425T3 (es) 2002-11-16

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97929226T Expired - Lifetime ES2175425T3 (es) 1996-06-20 1997-06-19 Antibiotico micrococcina para la prevencion y tratamiento de la mastitis.

Country Status (14)

Country Link
US (1) US6187800B1 (enExample)
EP (1) EP0934075B1 (enExample)
JP (1) JP2000513348A (enExample)
CN (1) CN1119170C (enExample)
AT (1) ATE215378T1 (enExample)
AU (1) AU720243B2 (enExample)
BR (1) BR9709812A (enExample)
CA (1) CA2251779A1 (enExample)
DE (1) DE69711661T2 (enExample)
DK (1) DK0934075T3 (enExample)
ES (1) ES2175425T3 (enExample)
IL (1) IL126489A0 (enExample)
PT (1) PT934075E (enExample)
WO (1) WO1997048408A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
EP1369425A1 (en) * 2001-03-13 2003-12-10 Yamanouchi Pharmaceutical Co. Ltd. Thiopeptide compounds
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
CN1226998C (zh) * 2002-06-28 2005-11-16 陈放 可控释型奶道栓
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
WO2008045920A2 (en) * 2006-10-10 2008-04-17 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
BRPI1016082B1 (pt) 2009-04-08 2020-12-22 Wisconsin Alumni Research Foundation selante intramamário de mamilos
MX2012004177A (es) 2009-10-12 2012-05-08 Boehringer Ingelheim Vetmed Recipiente para composiciones que comprenden meloxicam.
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
AU2014214547B2 (en) * 2013-02-08 2018-08-30 Luoda Pharma Limited Methods of treating topical microbial infections
EP2953624B1 (en) * 2013-02-08 2019-08-21 Luoda Pharma Limited Methods of treating microbial infections, including mastitis
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
WO2018125649A1 (en) * 2016-12-27 2018-07-05 Colgate-Palmolive Company Antiperspirant / deodorant composition
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
WO2022245150A1 (ko) * 2021-05-21 2022-11-24 주식회사 에이엔제이사이언스 마크로코신 화합물을 포함하는 약학적 조성물 및 마크로코신 화합물의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69427492T2 (de) * 1993-08-20 2002-04-18 Novartis Ag, Basel Verfahren zur prävention und behandlung der rindermastitis

Also Published As

Publication number Publication date
US6187800B1 (en) 2001-02-13
ATE215378T1 (de) 2002-04-15
JP2000513348A (ja) 2000-10-10
AU3341097A (en) 1998-01-07
AU720243B2 (en) 2000-05-25
WO1997048408A3 (en) 1998-02-19
DE69711661T2 (de) 2002-10-17
BR9709812A (pt) 1999-08-10
EP0934075B1 (en) 2002-04-03
CN1119170C (zh) 2003-08-27
IL126489A0 (en) 1999-08-17
DK0934075T3 (da) 2002-06-10
PT934075E (pt) 2002-08-30
DE69711661D1 (de) 2002-05-08
CN1222081A (zh) 1999-07-07
CA2251779A1 (en) 1997-12-24
EP0934075A2 (en) 1999-08-11
WO1997048408A2 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
PT934075E (pt) Metodo para a prevencao e tratamento da mastite
ES2074563T3 (es) Procedimiento de preparacion de compuestos y metodo para el tratamiento de la septicemia y/o el choque septico.
MA25009A1 (fr) Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes
AU2003291227A8 (en) Antibacterial agents
BR9510423A (pt) Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
WO2004058144A3 (en) Antibacterial agents
TW200507841A (en) Antibacterial agents
BR9805032A (pt) Embalagem ventilada de barreira microbiana para dispositivos médicos estéreis e método de embalagem.
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
DE60331849D1 (de) Antibakterielle wirkstoffe
AU6289196A (en) A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
WO2008039923A3 (en) Two part antimicrobial boot
HU0201043D0 (enExample)
BR9904150A (pt) Composições de proteìnas estabilizadas
BR0110382A (pt) Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
ES2161762T3 (es) Polimeros de ionenos como antihelminticos en animales.
WO2000030435A3 (en) Foulbrood treatments
DE69717988D1 (de) Topische verabreichung von premafloxacin zur behandlung von systemischen bakteriellen erkrankungen
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
WO2002006821A3 (en) Antimicrobial agent
ES2157985T3 (es) Metodo para la prevencion y el tratamiento de la mastitis bovina.
PT1156795E (pt) Utilizacao de acido succinico ou de seus sais e metodo de tratamento da resistencia a insulina
CO5031290A1 (es) Formulacion lo
BR9712633A (pt) Método para o tratamento de infecção por streptococcus pneumoniae

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 934075

Country of ref document: ES